Author: admin

Author: admin

The Complete Guide to Peptide Therapy in 2026

Everything you need to know about physician-prescribed peptide therapy in 2026 — in one comprehensive guide.

Peptide Therapy Cost in 2026: What to Expect to Pay

"Cost of peptide therapy" searches increased 300% in the past year. Here's a complete breakdown of what you'll…

BPC-157 Is Legal Again in 2026: What the FDA Reclassification Actually Means

On February 27, 2026, HHS Secretary RFK Jr. announced that BPC-157 would move back to Category 1 —…

Founding Member Offer: What Early Access to My Body Labs Includes

My Body Labs founding member access is a limited enrollment. Here's exactly what it includes and why it…

How Peptide Therapy Platforms Make Money: Understanding the Business Model

Understanding how peptide therapy platforms make money helps you evaluate their incentives. Here's a transparent look at the…

Peptide Therapy and Diabetes: What Physicians Consider

Diabetes or insulin resistance significantly affects peptide therapy evaluation. Here's what physicians assess before prescribing.

Thymosin Beta-4 Fragment vs Full Thymosin Beta-4: What’s the Difference?

TB-500 is not Thymosin Beta-4 — it's a fragment of it. Here's what that distinction means in practice.

NAD+ Precursors vs IV NAD+: What’s the Difference?

NMN supplements vs IV NAD+ vs subcutaneous NAD+: an honest comparison of bioavailability, cost, and clinical relevance.

Peptide Therapy and Cancer: Important Considerations

Cancer history is one of the most important factors in peptide therapy evaluation. Here's what physicians assess and…

For informational purposes only. My Body Labs is a telehealth technology platform. All treatments require evaluation and prescription from a licensed physician. Compounded medications are not FDA-approved finished products. Individual results vary. Not a substitute for professional medical advice.